vs
Side-by-side financial comparison of iQSTEL Inc (IQST) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
iQSTEL Inc is the larger business by last-quarter revenue ($84.2M vs $47.7M, roughly 1.8× IRONWOOD PHARMACEUTICALS INC). iQSTEL Inc runs the higher net margin — -3.2% vs -4.8%, a 1.6% gap on every dollar of revenue. On growth, iQSTEL Inc posted the faster year-over-year revenue change (-14.9% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-1.2M). Over the past eight quarters, iQSTEL Inc's revenue compounded faster (28.0% CAGR vs -20.2%).
iQSTEL Inc is a technology holding company operating three core segments: telecommunications, Internet of Things (IoT), and fintech. It offers connectivity services, smart IoT monitoring solutions, and digital financial tools, mainly serving small and medium-sized enterprises and retail customers in North and South American markets.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
IQST vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $84.2M | $47.7M |
| Net Profit | $-2.7M | $-2.3M |
| Gross Margin | 3.5% | — |
| Operating Margin | -2.9% | 14.3% |
| Net Margin | -3.2% | -4.8% |
| Revenue YoY | -14.9% | -47.3% |
| Net Profit YoY | -44.5% | -200.9% |
| EPS (diluted) | $-0.92 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $84.2M | $47.7M | ||
| Q3 25 | $102.9M | $122.1M | ||
| Q2 25 | $72.2M | $85.2M | ||
| Q1 25 | $57.6M | $41.1M | ||
| Q4 24 | $98.9M | $90.5M | ||
| Q3 24 | $54.2M | $91.6M | ||
| Q2 24 | $78.6M | $94.4M | ||
| Q1 24 | $51.4M | $74.9M |
| Q4 25 | $-2.7M | $-2.3M | ||
| Q3 25 | $-2.3M | $40.1M | ||
| Q2 25 | $-2.3M | $23.6M | ||
| Q1 25 | $-1.1M | $-37.4M | ||
| Q4 24 | $-1.9M | $2.3M | ||
| Q3 24 | $-773.0K | $3.6M | ||
| Q2 24 | $-2.0M | $-860.0K | ||
| Q1 24 | $-580.2K | $-4.2M |
| Q4 25 | 3.5% | — | ||
| Q3 25 | 2.7% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 3.4% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 3.7% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 2.7% | — |
| Q4 25 | -2.9% | 14.3% | ||
| Q3 25 | -0.5% | 61.8% | ||
| Q2 25 | -0.9% | 53.2% | ||
| Q1 25 | -1.0% | -70.7% | ||
| Q4 24 | -0.3% | 34.8% | ||
| Q3 24 | -0.1% | 28.0% | ||
| Q2 24 | -0.4% | 26.5% | ||
| Q1 24 | -0.4% | 14.7% |
| Q4 25 | -3.2% | -4.8% | ||
| Q3 25 | -2.3% | 32.8% | ||
| Q2 25 | -3.3% | 27.7% | ||
| Q1 25 | -2.0% | -90.9% | ||
| Q4 24 | -1.9% | 2.5% | ||
| Q3 24 | -1.4% | 4.0% | ||
| Q2 24 | -2.5% | -0.9% | ||
| Q1 24 | -1.1% | -5.6% |
| Q4 25 | $-0.92 | $0.01 | ||
| Q3 25 | $-0.68 | $0.23 | ||
| Q2 25 | $-0.82 | $0.14 | ||
| Q1 25 | $-0.44 | $-0.23 | ||
| Q4 24 | $-1.19 | $0.03 | ||
| Q3 24 | $-0.40 | $0.02 | ||
| Q2 24 | $-0.90 | $-0.01 | ||
| Q1 24 | $-0.37 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.2M | $215.5M |
| Total DebtLower is stronger | $4.1M | — |
| Stockholders' EquityBook value | $16.3M | $-261.8M |
| Total Assets | $51.1M | $396.9M |
| Debt / EquityLower = less leverage | 0.25× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.2M | $215.5M | ||
| Q3 25 | $2.3M | $140.4M | ||
| Q2 25 | $2.0M | $92.9M | ||
| Q1 25 | $1.1M | $108.5M | ||
| Q4 24 | $2.5M | $88.6M | ||
| Q3 24 | $2.1M | $88.2M | ||
| Q2 24 | $797.2K | $105.5M | ||
| Q1 24 | $2.7M | $121.5M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $2.7M | $199.5M | ||
| Q2 25 | $4.5M | $199.3M | ||
| Q1 25 | $3.5M | $199.2M | ||
| Q4 24 | $2.5M | $199.0M | ||
| Q3 24 | $3.2M | $198.8M | ||
| Q2 24 | $2.5M | $198.6M | ||
| Q1 24 | $194.0K | $398.3M |
| Q4 25 | $16.3M | $-261.8M | ||
| Q3 25 | $17.9M | $-264.2M | ||
| Q2 25 | $14.3M | $-308.2M | ||
| Q1 25 | $11.6M | $-334.1M | ||
| Q4 24 | $11.9M | $-301.3M | ||
| Q3 24 | $8.1M | $-311.3M | ||
| Q2 24 | $7.6M | $-321.7M | ||
| Q1 24 | $8.4M | $-330.5M |
| Q4 25 | $51.1M | $396.9M | ||
| Q3 25 | $46.9M | $396.1M | ||
| Q2 25 | $51.4M | $342.9M | ||
| Q1 25 | $42.0M | $327.2M | ||
| Q4 24 | $79.0M | $350.9M | ||
| Q3 24 | $32.4M | $389.5M | ||
| Q2 24 | $30.0M | $395.6M | ||
| Q1 24 | $22.1M | $438.8M |
| Q4 25 | 0.25× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.31× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2M | $74.6M |
| Free Cash FlowOCF − Capex | $-1.2M | $74.6M |
| FCF MarginFCF / Revenue | -1.5% | 156.3% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-4.0M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.2M | $74.6M | ||
| Q3 25 | $-953.0K | $47.6M | ||
| Q2 25 | $257.7K | $-15.1M | ||
| Q1 25 | $-1.9M | $20.0M | ||
| Q4 24 | $-403.7K | $15.2M | ||
| Q3 24 | $625.0K | $9.9M | ||
| Q2 24 | $-2.6M | $33.5M | ||
| Q1 24 | $-536.9K | $45.0M |
| Q4 25 | $-1.2M | $74.6M | ||
| Q3 25 | $-969.2K | $47.6M | ||
| Q2 25 | $211.7K | $-15.1M | ||
| Q1 25 | $-2.0M | $19.9M | ||
| Q4 24 | $-421.3K | — | ||
| Q3 24 | $594.5K | $9.9M | ||
| Q2 24 | $-2.6M | $33.4M | ||
| Q1 24 | $-608.5K | $44.9M |
| Q4 25 | -1.5% | 156.3% | ||
| Q3 25 | -0.9% | 39.0% | ||
| Q2 25 | 0.3% | -17.7% | ||
| Q1 25 | -3.4% | 48.4% | ||
| Q4 24 | -0.4% | — | ||
| Q3 24 | 1.1% | 10.8% | ||
| Q2 24 | -3.4% | 35.4% | ||
| Q1 24 | -1.2% | 60.0% |
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.1% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IQST
| USA | $53.2M | 63% |
| Other | $29.9M | 35% |
| Switzerland | $1.1M | 1% |
IRWD
Segment breakdown not available.
